Exabis Library
Welcome to the e-CCO Library!
P226: Dietary patterns differ in the newly diagnosed IBD cohort with ethnicity as a key confounding variable, a case control study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P226: Does faecal Calprotectin help differentiate inflammatory from fibrous stenosis in Crohn’s disease?
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P226: Nuclear magnetic resonance spectroscopy measure of protein glycosylation is a biomarker of activity and metabolic complications in Inflammatory Bowel Disease.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P226: Relevant factors and significant endoscopic findings for detecting colitis-associated neoplasms using pancolonic narrow band imaging surveillance colonoscopy in patients with ulcerative colitis: A sub-analysis of prospective randomised trial
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P226: Systematic review with meta-analysis of individual data: impact of cut-off values on the performance of faecal calprotectin to detect endoscopic recurrence after intestinal resection in patients with Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P226: The first validated post-operative endoscopic Crohn’s disease index: the POCER index— identification of key endoscopic prognostic factors
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P227 Defining faecal calprotectin thresholds to predict endoscopic and histological healing in ulcerative colitis (UC) by using advanced optical enhancement techniques
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P227: A web-based telemanagement system for patients with complex Inflammatory Bowel Disease (TECCU): Results of a randomised controlled clinical trial
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P227: Association between pouchitis and faecal calprotectin following restorative proctocolectomy in patients with ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P227: Faecal calprotectin reductions in patients achieving mucosal healing with vedolizumab induction therapy in GEMINI 1
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P227: High prevalence of mental health illness in IBD patients with high caregiver burden in the developing world: An analysis of risk factors from the IBD Emerging Nations Consortium (IBD-ENC)
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P227: Outcomes of anti-TNF versus Vedolizumab therapy for ulcerative colitis: the Leeds experience
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P227: Patient experiences in ulcerative colitis: conceptual model and review of patient-reported outcome measures
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P227: Timing of acute severe colitis in the course of an inflammatory bowel disease: is it a prognostic factor?
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P228 Cytomegalovirus Infection: is it a cause of flare-up in inflammatory bowel diseases?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P228: Appendiceal Orifice Inflammation Is Associated with Lower Rate of Complete Endoscopic Remission in Patients with Ulcerative Colitis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P228: Machine learning models utilizing simple laboratory tests may assess endoscopic activity in ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P228: Prehabilitation strategies prior to ileocolonic resection in Crohn’s disease in a prospective cohort study: a missed window of opportunity?
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P228: Preliminary Evaluation of a new immunofluorescence mosaic assay for inflammatory bowel disease diagnosis: a pilot study in Udine
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P228: Prevalence and risk factor of CMV infection among hospitalized patients with ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM